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Tropheryma whipplei, the etiological agent of Whipple’s disease, is an intracellular bacterium that infects macrophages. We
previously showed that infection of macrophages results in M2 polarization associated with induction of apoptosis and
interleukin (IL)-16 secretion. In patients with Whipple’s disease, circulating levels of apoptotic markers and IL-16 are increased
and correlate with the activity of the disease. To gain insight into the understanding of the pathophysiology of this rare disease,
we examined the molecular pathways involved in T. whipplei-induced apoptosis of human macrophages. Our data showed that
apoptosis induction depended on bacterial viability and inhibition of bacterial protein synthesis reduced the apoptotic program
elicited by T. whipplei. Induction of apoptosis was also associated with a massive degradation of both pro- and anti-apoptotic
mediators. Caspase-speciﬁc inhibition experiments revealed that initiator caspases 8 and 10 were required for apoptosis, in
contrast to caspases 2 and 9, in spite of cytochrome-c release from mitochondria. Finally, the effector caspases 3 and 6 were
mandatory for apoptosis induction. Collectively, these data suggest that T. whipplei induces apoptosis through the extrinsic
pathway and that, beside M2 polarization of macrophages, apoptosis induction contributes to bacterial replication and
represents a virulence trait of this intracellular pathogen.
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Whipple’s disease is a rare systemic chronic disease caused
by the intracellular pathogen Tropheryma whipplei. This
rod-shaped microorganism is a Gram-positive bacterium,
classiﬁed in the Actinobacteria phylum. Classical symptoms
of Whipple’s disease associate diarrhea, weight loss,
abdominal pain, arthralgia, fever and lymphadenopathy.
1
The most severe manifestation of Whipple’s disease involves
the central nervous system, with disturbance of cognitive
functions. Diagnosis of Whipple’s disease is usually carried
out after Periodic-acid Schiff staining of biological samples
and PCR.
1 However, it has been shown that T. whipplei may
be detected in healthy individuals without any clinical signs of
Whipple’s disease.
2 Immunopathology of Whipple’s disease
starts to be elucidated. We previously showed that macro-
phages from patients with Whipple’s disease present an
alternatively activated phenotype characterized by the
expression of arginase, CCL18, cathepsins, scavenger
receptor, interleukin (IL)-10 and lipid metabolites.
3 In addition,
T. whipplei replicates in human macrophages through
an IL-16-dependent mechanism, whereas bacteria are
eliminated in monocytes.
4 Indeed, the production of IL-16 by
macrophages in response to T. whipplei is critical for bacterial
replication because blocking IL-16 results in bacterial clear-
ance. Conversely, addition of IL-16 to monocytes allows the
bacteria to replicate at levels comparable to those observed
in macrophages.
4 Finally, T. whipplei induces macrophage
apoptosis.
4 These results were further strengthened by the
fact that, in patients, circulating levels of IL-16 and apoptosis
markers correlate with the severity of the disease.
5
Apoptosis or programmed cell death is a physiological
process critical for the maintenance of the immune system.
Two pathways govern apoptosis induction, namely the
intrinsic and the extrinsic pathways. The intrinsic pathway is
initiated from cellular stress signals and involves activation
of Bcl-2-like pro-apoptotic proteins of the Bax group (Bax and
Bak), which oligomerize and permeabilize the mitochondrial
membrane, resulting in cytochrome-c release and initiator
caspase activation through apoptosome assembly. Activation
of initiator caspases (caspases 2, 8, 9 and 10) induces an
expanding cascade that ultimately leads to activation of
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www.nature.com/cddiseffectorcaspases(caspases3,6 and7), which initiate cleavage
of speciﬁc cellular substrates and thus apoptosis.
6The extrinsic
pathwayofapoptosisistriggeredafterbindingofapro-apoptotic
ligandtodeathreceptors,whichinducesreceptorclusteringand
recruitment of adapter proteins that directly activate initiator
caspases, thereby converging to the intrinsic pathway.
6
Apoptosis can promote efﬁcient pathogen clearance be-
cause the deathofthe host cell is generally associated withthe
death of the infecting agent. However, several microorganisms
have evolved strategies to modulate apoptotic response in the
course of infection. Indeed, some of them, such as Rickettsia
rickettsii or Chlamydia spp., prevent cell death to replicate
intensively within host cells,
7,8 while others, such as Yersinia
pestis or Bacillus anthracis, induce apoptosis to favor bacterial
spreading.
9,10 In this report, we aimed to examine the
molecular pathway induced by T. whipplei to promote macro-
phage apoptosis. Our results showed that T. whipplei-induced
macrophage apoptosis involved the repression of numerous
anti-apoptoticmediators,cytochrome-creleasefrommitochon-
dria, and caspase 8/10 and 3/6 activation, leading to IL-16
production and favoring bacterial replication.
Results
T. whipplei induces apoptosis of human MDM. To
evaluate the effects of T. whipplei on monocyte-derived
macrophage (MDM) apoptosis, cells were infected for 4h
with T. whipplei, washed to discard unbound bacteria and
incubated for 24 and 48h before Annexin V staining.
T. whipplei induced MDM apoptosis in a time-dependent
manner (Figure 1a). Indeed, at 24h, 11.5±4.5% of infected
MDM were apoptotic, and this percentage increased to
20.1±3.9% for MDM incubated for 48h, versus 3.8±1.6 and
3.9±1.0% for uninfected MDM incubated for 24 and 48h,
respectively. This result is similar to ﬁndings previously
observed.
4 Interestingly, heat-killed bacteria did not induce
signiﬁcant MDM apoptosis (8.5±1.5%). Transmission
electron microscopy (TEM) observation of MDM incubated
for 48h after infection conﬁrmed annexin V ﬁndings. MDM
showed characteristic features of apoptosis, including
vacuolation and chromatin condensation (Figure 1b). To
examine whether de novo T. whipplei protein synthesis was
required for inducing apoptosis, MDM were infected with
T. whipplei in the presence of the bacterial protein synthesis
inhibitor, chloramphenicol. We found that chloramphenicol
dramatically reduced T. whipplei-induced apoptosis, while it
had no effect on UV-induced apoptosis of MDM (Figure 1c).
To avoid any bias resulting from the effects of chloram-
phenicol on mitochondrial protein synthesis, we used another
bacterial protein synthesis inhibitor, streptomycin. As
observed with chloramphenicol, streptomycin dramatically
reduced apoptosis induced by T. whipplei (data not shown).
Collectively, these results show that T. whipplei induces
macrophage apoptosis and suggest that de novo protein
synthesis is required for apoptosis induction.
T. whipplei infection results in a massive degradation of
apoptosis-related proteins. To better characterize mole-
cular events leading to MDM apoptosis after infection with
T. whipplei, we conducted an apoptosis-related protein
antibody array analysis of MDM infected or not with
T. whipplei. Nineteen proteins, either pro- or anti-apoptotic,
were signiﬁcantly modulated (Figure 2). Among proteins
known to mediate apoptosis, only levels of cleaved caspase
3 were increased (Po0.05) whereas Bad, Bax, FADD, Fas/
TNFSF6 and p27/Kip1 were either unchanged or repressed
(Figure 2a). Similarly, levels of most of anti-apoptotic proteins
Figure 1 T. whipplei inducesapoptosis of human MDM. (a) MDM were infected
withliveorheat-killed(HK)T.whipplei(MOI50:1)for4h,washedandincubatedfor
24 and 48h. Cells were then washed and stained with annexin V-FITC and PI and
analyzed by ﬂow cytometry. The data are the mean±S.D. of three independent
experiments. (b) Uninfected (left) and T. whipplei-infected (right) MDM were
observed by TEM after 48h of incubation. (c) T. whipplei-infected MDM were
incubated for 48h in the presence or not of chloramphenicol (Cm, 20mg/ml). As a
control, MDM were exposed to UV light. Apoptosis was determined by TUNEL
staining and quantiﬁed by examining 3–5 ﬁelds per condition (B100 cells per ﬁeld).
The percentage of TUNEL-positive cells was calculated as the ratio between
TUNEL-positiveandDAPI-stainednuclei  100.*Po0.05,Mann–Whitney’sU-test
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tosis family (IAPs) such as XIAP and livin were inhibited.
Members of the heat shock proteins (HSPs), Hsp27 and
Hsp70, as well as detoxifying enzymes such as catalase,
heme oxygenase 1 and 2 (HO-1 and HO-2), and para-
oxonase 2 (PON2) were also signiﬁcantly reduced by
T. whipplei (Figure 2b). Strikingly, one anti-apoptotic
protein, namely p21/CIP1/CDNK1A, was strongly increased
on infection. These ﬁndings suggest that T. whipplei infection
results in a marked modulation of apoptosis-related proteins.
T. whipplei induces mitochondrial transmembrane
potential disturbance. To further examine the apoptotic
effect of T. whipplei infection, we monitored the decrease in
the mitochondrial transmembrane potential (Dcm) and the
release of cytochrome-c, which are associated with the
induction of apoptosis.
11 Changes in Dcm were analyzed
after incubation of MDM with the cationic dye DiOC6[3]
by ﬂow cytometry. As expected, mitochondria from
uninfected MDM retained DiOC6[3] and a marked decrease
of ﬂuorescence was observed when cells were treated with
staurosporine. When cells were infected with T. whipplei
and incubated for 24 and 48h, the ﬂuorescence decreased,
suggesting a leakage of DiOC6[3] from mitochondria
(Figure 3a). We also monitored cytochrome-c release by
immunoblot analysis. Cytochrome-c release into the
cytosolic fraction was detected after treatment of MDM
with staurosporine. For cells infected with T. whipplei,
cytochrome-c release started to be observed after 24h of
incubation and was evident at 48h (Figure 3b), thereby
conﬁrming the decrease of Dcm.
T. whipplei-induced apoptosis involves caspase
activity. To determine whether caspases are involved in
T. whipplei-induced apoptosis of MDM, we examined
the initiator caspases, caspase 8 and caspase 9, and the
executioner caspase, caspase 3. As determined by western
blot, we found that the expression of caspase 8 was induced
within 24h and increased further at 48h, but we were not
able to observe caspase 9 expression (Figure 3b). As
expected for its role in the initiation of apoptosis, caspase 8
induction occurred early before cell death because it was
detectable at 6h while MDM apoptosis became signiﬁcantly
increased at 24 and 48h after infection (Supplementary
Figure 1). The executioner caspase 3 was clearly activated
48h after infection of MDM with T. whipplei, as shown by
immunoﬂuorescence (Figure 3c). To further analyze the role
of caspases in T. whipplei-induced apoptosis, we performed
caspase inhibition experiments using the pan caspase
inhibitor (Z-VAD-FMK), the initiator caspase 2-, 8-, 9-
and 10-speciﬁc inhibitors, Z-VDVAD-FMK, Z-IETD-FMK,
Z-LEHD-FMK and Z-AEVD-FMK, respectively, and the
effector caspase 3- and 6-speciﬁc inhibitors, Z-DEVD-FMK
and Z-VEID-FMK, respectively (Figure 3d). Treatment of
MDM with the pan caspase inhibitor completely abolished
T. whipplei-induced apoptosis. In addition, we found that
T. whipplei activated speciﬁc initiator caspases. Indeed,
inhibition of caspase 8 and caspase 10 resulted in a
signiﬁcant reduction of the percentage of apoptotic cells
whereas inhibition of caspase 2 and caspase 9 had no effect
(Figure 3d). In contrast, we found that the executioner
caspases were necessary for T. whipplei-induced apoptosis
as the inhibition of both caspase 3 and caspase 6 signiﬁcantly
prevented apoptosis (Figure 3d). These ﬁndings suggest
that T. whipplei-induced apoptosis requires activities of the
initiator caspase 8/10 and the executioner caspase 3/6.
Activated caspase 3 is known to initiate the cleavage of
speciﬁc cellular substrates.
6 We thus analyzed the cleavage
of one of its substrates that has also been involved during
Whipple’s disease, pro-IL-16. Immunoblot analysis showed
that infection with T. whipplei caused the cleavage of pro-IL-
16 in a time-dependent manner to yield the biologically active
IL-16. Pro-IL-16 cleavage products were evidenced at 24h
and their levels increased at 48h (Figure 3e, arrows). As a
result, biologically active IL-16 was in turn secreted by MDM
Figure 2 T. whipplei modulates the cellular content of pro- and anti-apoptotic
mediators. MDM were infected with T. whipplei (MOI 50:1) for 4h, washed and
incubated for 24h. Cell lysates were applied on a human apoptosis protein array.
Theaveragedensityofduplicatespotsrepresentingeachpro-apoptotic(a)andanti-
apoptotic (b) proteins was expressed in arbitrary units (AU). Signiﬁcant changes in
protein expression after T. whipplei infection were determined by two-way ANOVA
(*Po0.05; ***Po0.001)
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induced by T. whipplei involves caspase activation.
Apoptosis induction favors T. whipplei replication in
macrophages. Finally, to determine whether apoptosis
induction contributes to bacterial replication, we prevented
T. whipplei-induced apoptosis and monitored bacterial
replication by real-time quantitative PCR. Single inhibition
of caspases 8 and 10 resulted in a 64.7 and 67.8% apoptosis
inhibition, respectively (Figure 3d). We wondered if double
inhibition of caspases 8 and 10 would inhibit even more the
cell death induced by T. whipplei. Simultaneous treatment of
MDM with both caspase 8 and caspase 10 inhibitors reduced
T. whipplei-induced apoptosis by 67.6% reduction, which
was similar to the reduction observed with single inhibitors
(Figure 4a). These results suggest that both caspase 8
and caspase 10 are required for apoptosis induction after
T. whipplei infection and that one might act upstream of the
other. Next, we followed bacterial replication over a 12-day
period. In the absence of inhibitors, T. whipplei replicates
in MDM as previously described.
4 After 4h (uptake), around
3000 T. whipplei DNA copies were detected. In the ﬁrst
3 days, bacterial DNA copy number decreased and started
to increase after 6 days to reach around 30000 copies after
12 days. In contrast, in the presence of caspase 8 and 10
inhibitors, replication of T. whipplei was signiﬁcantly reduced
in MDM, as around 10000 DNA copies were detected at day
12 (Figure 4b). Overall, these results suggest that apoptosis
induction contributes to macrophage permissivity toward
T. whipplei.
Discussion
One of the most striking characteristics of Whipple’s disease
is the accumulation of T. whipplei organisms in macrophages
in the duodenal mucosa, suggesting that macrophages are
the target of an effective immune evasion strategy of
T. whipplei.
3,12 Macrophages are long-lived cells that have a
Figure 3 T. whipplei triggers Dcm disturbance and caspase activation. MDM were infected with T. whipplei (MOI 50:1) for 4h, washed and incubated for additional
periods. As a control, MDM were treated with staurosporine (Staur) for 6h. (a) Cells were incubated with DiOC6[3] and ﬂuorescence was monitored by ﬂow cytometry. The
results are representative of two independent experiments (gray line: uninfected cells; black line: staurosporine-treated cells; blue and red line: MDM incubated 24 and 48h
after infection, respectively). (b) MDM lysates were analyzed by immunoblotting for cytochrome-c, caspase 8, caspase 9 or a-tubulin as loading control. One representative
experiment is shown (n¼2). (c) Caspase 3 activity was determined by immunoﬂuorescence using active caspase 3-speciﬁc antibodies. (d) MDM were infected with
T. whipplei (MOI 50:1) for 4h, washed and incubated for 24 and 48h in the presence of different caspase inhibitors. Apoptosis was determined by TUNEL staining and
quantiﬁedbyexamining3–5ﬁeldspercondition.ThepercentageofTUNEL-positivecellswascalculatedastheratiobetweenTUNEL-positiveandDAPI-stainednuclei  100.
(e) MDM lysates were analyzed by immunoblotting for IL-16 and a-tubulin as loading control. Arrows represent the cleaved forms of IL-16. One representative experiment is
shown (n¼2). (f) MDM supernatants were assessed for IL-16 by ELISA. The data are the mean±S.D. of three experiments. *Po0.05, Mann–Whitney’s U-test
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tion. We previously showed that T. whipplei induces macro-
phage apoptosis
4 and that apoptotic markers were increased
in patients with active Whipple’s disease.
5 In addition,
apoptosis induction is associated with the M2 polarization of
macrophages, thereby constituting a favorable niche for
bacterial replication.
3 In this report, we aimed at deﬁning the
molecular events leading to macrophage apoptosis after
infection with T. whipplei. We found that apoptosis induction
required bacterial viability and de novo protein synthesis,
as cells infected with heat-killed bacteria or treated with
chloramphenicol or streptomycin did not undergo apoptosis.
Modulation of apoptosis by bacterial proteins synthetized de
novo has already been observed in other models of infection,
such as Coxiella burnetii
13 or Mycobacterium tuberculosis.
14
Induction of apoptosis was associated with a disturbance of
pro- and anti-apoptotic mediators. A majority of them were
repressed after infection except cleaved-caspase 3 and p21/
CIP1/CDNK1A, which were markedly induced. The increased
activity of caspase 3 can be linked to the diminution of cellular
IAP levels (mainly XIAP, but also livin). Indeed, IAPs are
potent inhibitors of caspases, and their repression might
change the balance toward apoptosis. Induction of apoptosis
may also be linked to the signiﬁcant reduction of detoxifying/
repair proteins, as well as HO-1 and HO-2. HO-1 is an
inducible HSP (Hsp32), which is upregulated in stress
conditions and reﬂects oxidative stress both in vivo and
in vitro.
15 HO-1 has been shown to inhibit apoptosis of various
cell types, including monocytes/macrophages.
16 HO-2 is
constitutively expressed and also appears as a critical
regulator of apoptosis by controlling levels of extracellular
superoxide dismutase and apoptotic signaling kinase-1.
17 We
also found that cellular levels of chaperones (Hsp27 and
Hsp70) and repair enzymes, such as PON2 or detoxifying
enzymes, such as catalase, were diminished after T. whipplei
infection. The deregulation of these proteins might severely
impair detoxiﬁcation of reactive oxygen species (ROS) and
thus contribute to apoptosis induction. This hypothesis is
strengthened by the fact that other redox-related molecules,
such as thioredoxin and glutaredoxin, have been shown to be
repressed in macrophages after infection by T. whipplei.
4
MDM apoptosis induced by T. whipplei was associated with
a decrease of Dcm, and the release of cytochrome-c in the
cytosol. M. tuberculosis-infected macrophages also undergo
apoptosis, and virulence of M. tuberculosis is correlated
with mitochondrial cytochrome-c release.
18 In the case of
T. whipplei, the decrease of anti-oxidant mechanisms
(see above) may lead to ROS accumulation, resulting in a
Dcm decrease and cytochrome-c release from the mitochon-
drial membrane.
19 Cytochrome-c release in the cytosol in
turn activates caspase 9 after binding to Apaf-1 through
formation of the apoptosome.
20 Nevertheless, we were
not able to detect caspase 9 activation, or modulation of
caspase 9 steady-state protein levels after T. whipplei
infection. In addition, its speciﬁc inhibition had no apparent
effect on T. whipplei-induced apoptosis whereas caspase 3
appeared critical. As cytochrome-c can inhibit caspase 9
activity in vitro,
21 it is therefore possible that caspase 3 acts
upstream of mitochondria, resulting in Dcm decrease as it
has been already described.
22
We then treated MDM with speciﬁc inhibitors of initiator
caspases. Caspase 2 and caspase 9, which are primarily
activated through the intrinsic pathway,
23 were not involved in
MDM apoptosis induced by T. whipplei, as their respective
inhibition had no effect. In contrast, the initiator caspases 8
and 10 were required for apoptosis induction. Caspase 8 is
primarily activated through the extrinsic apoptosis pathway:
stimulation of death receptors of the tumor necrosis factor
(TNF) receptor superfamily results in the activation of the
initiator caspase 8. Recently, we found in murine macro-
phages that T. whipplei induces after 6h the overexpression
of the genes encoding Fas, TRAIL, but also type I IFN, which
is involved in apoptosis induction.
24 It is tempting to speculate
that caspase 8 was activated after stimulation of death
receptors. However, we found here that the steady-state
protein levels of Fas, TRAIL R2 but also FADD were
decreased 24h after infection. These discrepancies between
transcriptional and protein data might arise from a post-
transcriptional regulation of mRNA, or alternatively, Fas,
TRAIL R2 and FADD might readily be synthesized, and
degraded later on, when apoptosis is engaged. In addition,
type I IFNs have been clearly shown to induce apoptosis and
activate the caspase 8 signaling and the caspase cascade.
25
Figure 4 Apoptosis induction is required for T. whipplei replication. (a) MDM
were infected with T. whipplei (MOI 50:1) for 4h, washed and incubated for 48h in
the presence of caspase 8 inhibitor, caspase 10 inhibitor, or both. Apoptosis was
determinedbyTUNELstainingandquantiﬁedbyexamining3–5ﬁeldspercondition.
The percentage of TUNEL-positive cells was calculated as the ratio between
TUNEL-positive and DAPI-stained nuclei  100 (control: uninfected cells after
incubation for 48h). (b) MDM were infected with T. whipplei (MOI 50:1) for 4h
(uptake), washed and incubated for different periods in the presence of both
caspase8 and10 inhibitors.Levels of bacterial DNA copynumber weredetermined
by qPCR (n¼3). *Po0.05, Mann–Whitney’s U-test
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also recruited after engagement of death receptors and acts
upstream of caspase 3.
26 Collectively, these data strongly
suggest that T. whipplei-induced apoptosis follows the
extrinsic pathway.
We also showed that the effector caspases 3 and 6 were
involved and required for apoptosis induction. It has been
shown that activation of caspase 3 results in the activation of
caspase 6 and that, at least in vitro, caspase 6 can process
pro-caspase 3, thus resulting in an ampliﬁcation cycle.
26 In
addition, pro-IL-16, one of the caspase 3 targets,
27 was
cleaved, resulting in the secretion of bioactive IL-16 by MDM.
Thus, during T. whipplei infection, apoptosis and IL-16 are
intimately associated. In patients with active Whipple’s
disease, circulating apoptotic markers and IL-16 levels are
correlated.
5 Successful treatment of patients results in the
decrease of circulating apoptotic markers and IL-16 levels,
while they are increased when patients relapse.
5 Moreover,
macrophages from these patients are characterized by M2
polarization.
3 Interestingly, we found that one of the proteins
thatwasupregulatedinresponsetoT.whippleiwasp21/CIP1/
CDNK1A,alsoknownasp21
Cip1/WAF1.p21
Cip1/WAF1isacyclin-
dependent kinase (CDK) inhibitor, which belongs to the Cip/
Kip family.
28 Initially described as promoting cell cycle arrest,
p21
Cip1/WAF1 has also been shown to be a critical regulator of
apoptosis and differentiation.
29 p21
Cip1/WAF1 protects cells
against apoptosis through its CDK inhibitory activity, but also
by controlling activity of transcription factors such as E2F1,
c-MycorSTAT3.p21canalsobinddirectlytopro-caspase-3or
to JNK kinases, thereby inhibiting their activation.
28 However,
p21
Cip1/WAF1 has also been reported to have a pro-apoptotic
role, depending on the cell type and apoptotic stimulus.
30 In
those cases, expression of p21
Cip1/WAF1 appears STAT1-
dependent.
31 It is interesting to note that T. whipplei induces
STAT1activationinantypeIIFN-dependentmechanism
24and
that type I IFN activates the p21 gene promoter and induces
p21
Cip1/WAF1 expression.
32 Beyond these cell cycle/apoptosis
functions, recent ﬁndings have shown a novel role for p21 as a
negative regulator of macrophage activation, independently of
cellcycleorapoptosis.
33,34Indeed,micedeﬁcientforp21show
increased susceptibility to endotoxic shock, associated
with increased circulating levels of IL-1b.
34 In LPS-stimulated
p21-deﬁcient macrophages, activity of the transcription factor
NF-kB is increased, resulting in the over-production of
pro-inﬂammatory mediators, such as TNF and IL-1b.
33 We
previouslyfoundthatmacrophageresponsestoT.whippleiare
characterized by the absence of pro-inﬂammatory mediators
and M2 polarization.
12,24 Hence, we can hypothesize that
T. whipplei modulates macrophage activation, at least by
increasing cellular p21 levels.
Finally,weshowedherethatapoptosisinductionwaslinked
to T. whipplei replication: prevention of apoptosis by inhibiting
the initiator caspases 8 and 10 resulted in a marked reduction
of bacterial replication. Clearance of apoptosis cells by
professional phagocytes such as macrophages results in a
powerful anti-inﬂammatory and immunosuppressive effect.
35
In another infection model, it has been shown that phago-
cytosis of apoptotic cells by macrophages promotes their
M2 polarization, allowing intense C. burnetii intracellular
replication.
36 As a result, it is probable that, after apoptosis
induction by T. whipplei, ingestion of apoptotic cells by
surrounding macrophages triggers a potent anti-inﬂammatory
response, favoring bacterial replication. Therefore, apoptosis
induction and p21 overexpression might act in concert to
subvert macrophage responses, at least by modulating their
activation and polarization.
Inconclusion,weshowthatT.whippleiinducesapoptosisin
macrophages through a caspase 8- and caspase 3-depen-
dent pathway, associated with IL-16 secretion and the loss
of mitochondrial membrane potential. Our ﬁndings provide
promisinginsightintothehostcellresponsesduringWhipple’s
disease and offer molecular bases in the understanding of the
pathophysiology of Whipple’s disease.
Materials and Methods
Cell culture, bacterial infection and reagents. Monocytes were
isolated from buffy coats obtained at the French blood bank (Etablissement
Franc ¸ais du Sang) by ﬁcoll gradient centrifugation and CD14 selection with MACS
magnetic microbeads (Miltenyi Biotec, Paris, France). Isolated monocytes were
cultivated in RPMI 1640 mediumcontaining 10% heat-inactivated humanAB serum
and 2mM glutamine (Sigma, Saint Quentin Fallavier, France). After the ﬁrst 3 days,
medium was replaced by RPMI 1640 containing 10% fetal calf serum (FCS) and
2mM glutamine. After 7 days of culture, more than 85% of the resulting MDMs
expressed CD68 and were used for further experiments.
The strain Twist–Marseille of T. whipplei (CNCM I-2202) was cultured in HEL
cells and puriﬁed as described previously.
4 Bacteria were counted by indirect
immunoﬂuorescence and their viability was assessed using the LIVE/DEAD
BacLight bacterial viability kit (Invitrogen, Cergy Pontoise, France). Heat-killed
T. whipplei was prepared by heating at 801C for 1h. T. whipplei organisms (MOI
50:1) were added to MDM for 4h, washed to remove free bacteria and incubated
for different times in RPMI 1640 containing 10% FCS and 2mM glutamine.
In some experiments, apoptosis was induced using staurosporine (Sigma) at
500nM for 4–6h. As needed, 20mg/ml chloramphenicol or 10mg/ml streptomycin
(MIC¼1mg/mlforT.whippleiinMRC5cells
37)wasaddedtoMDMcultures.ForUV
irradiation experiments, seeded MDM were placed in a tissue culture hood at a
distance of 60cm from the UV-C light source as described previously.
38 For
caspase inhibition, MDM were incubated with 20mM of the pan caspase inhibitor
(Z-VAD-FMK), caspase 2 inhibitor (Z-VDVAD-FMK), caspase 8 inhibitor (Z-IETD-
FMK), caspase 9 inhibitor (Z-LEHD-FMK), caspase 10 inhibitor (Z-AEVD-FMK),
caspase 3 inhibitor (Z-DEVD-FMK) or caspase 6 inhibitor (Z-VEID-FMK) (all from
R&D Systems, Lille, France) for 1h before infection and maintained during the
course of the experiments.
Annexin V staining. Infected MDM, seeded on six-well plates at 10
6 cells per
well, were incubated for 24 and 48h, scrapped and then washed with PBS, before
staining with annexin V-ﬂuorescein isothiocyanate (FITC) and propidium iodide (PI)
accordingto themanufacturer’sprotocol(AbCys).Thepercentageofapoptoticcells
(annexin
þ/PI
 ) was determinedby ﬂow cytometry using a FACSCalibur (Beckman
Dickinson, Le Pont de Claix, France), and the data were analyzed with Cyﬂogic
software (CyFlo Ltd, Turku, Finland).
Human apoptosis protein array. To compare the levels of apoptosis-
related proteins before and after T. whipplei infection, a human apoptosis protein
array (R&D Systems) was used according to manufacturer’s instructions. Brieﬂy,
MDM were infected with T. whipplei for 4h, washed and incubated for 24h. Protein
lysates(500mg)wereincubatedontoanarraymembraneat41Covernight,washed
three times for 5min, and then incubated with a horseradish peroxidase (HRP)-
linked secondary antibody at a dilution of 1:2000. After washing, blotting dots were
visualized by Immobilon Western Chemiluminescent HRP substrate (Millipore,
Guyancourt, France). Densitometry of proteindot signalswas obtained.Normalized
intensitieswerecalculatedfromeacharraybysubtractingthelocalbackgroundfrom
each spot, and the data were corrected for the protein content of each well. The
average density of duplicate spots representing each apoptosis-related protein
indicated its relative levels and expressed in arbitrary units. Signiﬁcant changes in
protein expression after T. whipplei infection were determined by two-way ANOVA
(Po0.05).
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2.5% glutaraldehyde diluted in 0.1M cacodylate buffer (pH 7.2) containing 0.1M
sucrose for 1h at 41C. After washing, cells were incubated with 1% osmium
tetroxide diluted in 0.1M cacodylate buffer for 1h. Dehydration was performed
through washes of graded concentrations of acetone (25–100%), and cells were
then embedded in Araldite (Sigma-Aldrich). Sections from embedded blocks were
post-stainedwith saturatedsolutionof methanol/uranylacetateandleadnitratewith
sodium citrate in water before examination using a JEOL 1220 electron microscope
(JEOL SAS, Croissy-sur-Seine, France).
Terminal transferase deoxytidyl uridine end labeling (TUNEL)
staining. Detection of apoptosis by TUNEL was performed using In situ Cell
Death Detection Kit, TMR red (Roche, Meylan, France) according to the
manufacturer’s instructions. After treatment as indicated, cells seeded on glass
coverslips were ﬁxed in 4% paraformaldehyde for 15min, washed in PBS and
permeabilized with 0.1% Triton-X100 in 0.1% sodium citrate for 2min. Cells were
then incubated with the TUNEL mixture containing TMR-dUTP and terminal
deoxynucleotidyl transferase for 1h. Cells were washed in PBS and nuclei were
stained with DAPI before mounting with Mowiol. Positive controls were carried out
by incubating cells with 3U/ml DNase I prior labeling procedures. Negative controls
were performed by incubating cells with label solution (without terminal
deoxynucleotidyl transferase). Apoptosis was quantiﬁed as follows. Coverslips
wereexaminedinﬂuorescencemodewithaLeicamicroscope(LeicaMicrosystems,
Nanterre, France) equipped with a Nikon digital camera (Nikon Instruments,
Champigny sur Marne, France) using a 10  objective lens. Three to ﬁve ﬁelds per
condition (100–300 cells each) were observed. The number of TUNEL-positive and
DAPI-stained nuclei was determined and the apoptosis percentage was expressed
as the ratio between TUNEL-positive and DAPI-stained nuclei  100.
Cytochrome-c release. Cytosolic fractions from MDM were prepared as
describedpreviously.
39Celllysateswereexaminedforequalamountsofproteinsby
the Bradford method using g globuline as a standard. Samples were loaded onto
10% sodium dodecyl sulfate (SDS) polyacrylamide gels, electrophoresed and
transferred onto nitrocellulose membranes (GE Healthcare, Saclay, France). The
membranes were blocked in PBS with 0.05% Tween 20 (PBST) supplemented with
3% powdered milk and then incubated with anti-cytochrome-c Ab (BD Pharmingen,
Le Pont de Claix, France) or a-tubulin Ab (Cell Signaling, Danvers, MA, USA) as a
loading control. The blots were washed with PBST and incubated with a secondary
Ab, either HRP-conjugated anti-rabbit or anti-mouse immunoglobulin (Pierce,
Rockford, IL, USA) in PBST plus 3% powdered milk. The bound Abs were detected
using Immobilon Western Chemiluminescent HRP substrate (Millipore).
Analysis of transmembrane mitochondrial potential (Dwm). The
analysis of Dcm was performed using the dye DiOC6[3]. This dye strongly labels
mitochondria and a decrease in Dcm in apoptotic cells is associated with a
reduction of DiOC6[3] uptake after ﬂow cytometry analysis.
40 In brief, MDM were
either treated with staurosporine for 6h, infected with T. whipplei for 4h and
incubated for additional times, or left untreated. Cells were then incubated with the
cationic at 20nM for 30min at 371C and analyzed by ﬂow cytometry.
Western blot analysis. At designated times after infection, MDM were
washedwithice-coldPBS.Cellswerethenscrappedinice-coldRIPAbuffer(20mM
Tris-HCl, 200mM NaCl, 1mM EDTA, 1% Triton -X100, pH 7.5) containing protease
inhibitor (Complete, Roche) and phosphatase inhibitor (Phosphostop, Roche)
cocktails. The cell lysates were cleared by centrifugation at 14000 r.p.m. for 15min
at 41C and stored at  801C. Samples were loaded onto 10% SDS polyacrylamide
gels, electrophoresed and transferred onto nitrocellulose membranes (Amersham)
before probing with Abs against caspase 8, caspase 9 (BD Pharmingen) or a-tubulin,
as indicated by the manufacturer. Bound Abs were detected as described above.
Caspase3activation. Direct caspase3activationwas determinedby indirect
immunoﬂuorescence as followed: 48h after infection, MDM were ﬁxed in 3% para-
formaldehyde and permeabilized with 0.1% Triton -X100. Immunoﬂuorescence
labeling was performed according to standard procedures. Brieﬂy, MDM were
incubatedwithrabbitanti-activecaspase3polyclonalAb(Biovision,MountainView,
CA, USA, 1:100 dilution) for 30min. Secondary anti-rabbit 488-Alexa Abs were
purchased from Invitrogen and used at a 1:500 dilution. Coverslips were mounted
with Mowiol and examined in ﬂuorescence mode with a Leica microscope equipped
with a Nikon digital camera using a 100  objective lens. Caspase 3 activation was
alsomonitoredthroughthecleavageofoneofitssubstrates,IL-16.
27IL-16cleavage
was determined by western blot as described above by incubating the membranes
with mouse monoclonal anti-IL-16 (R&D Systems). Alternatively, IL-16 protein
release was assessed in culture supernatant by ELISA (R&D Systems), according
to the manufacturer’s instructions.
Real-time quantitative PCR (qPCR). T. whipplei organisms (MOI 50:1)
were added to MDM for 4h, washed to remove free bacteria and incubated for 12
days in RPMI 1640 containing 10% FCS and 2mM glutamine. Every 3 days, MDM
were collected and DNA was extracted using the QIAamp DNA MiniKit (Qiagen,
Courtaboeuf, France). PCR was performed using the LightCycler-FastStart DNA
Master SYBR Green system (Roche), as previously described.
4
Statistical analysis. All experiments were performed at least two or three
times. Error bars represent S.D. *Po0.05, Mann–Whitney’s U-test.
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